Matches in Nanopublications for { ?s ?p "[Patients with stage IV neuroblastoma over the age of 500 days without MYCN amplification have a survival rate of <30% and there are currently no reliable means of predicting which of these patients will survive or succumb to the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP421705.RAqZ1nvGhlCI2ihnCNytreX7_RMSHFBkwZsKTRrtYYvDo130_assertion description "[Patients with stage IV neuroblastoma over the age of 500 days without MYCN amplification have a survival rate of <30% and there are currently no reliable means of predicting which of these patients will survive or succumb to the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421705.RAqZ1nvGhlCI2ihnCNytreX7_RMSHFBkwZsKTRrtYYvDo130_provenance.
- NP161755.RAwGxnwKVC-DkwzZB4GUc__gRuA9p3_OToax-Cf7jJv3o130_assertion description "[Patients with stage IV neuroblastoma over the age of 500 days without MYCN amplification have a survival rate of <30% and there are currently no reliable means of predicting which of these patients will survive or succumb to the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP161755.RAwGxnwKVC-DkwzZB4GUc__gRuA9p3_OToax-Cf7jJv3o130_provenance.